Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Haemonetics Corporation (HAE)
USD78.20
-1.64 (-2.05%)
US NYSE Healthcare Medical - Instruments & Supplies
Address
125 Summer Street 2110
Boston, MA, US
Boston, MA, US
CEO
Christopher A. Simon
Website
haemonetics.com
IPO
1991-05-10
CIK 313143 ISIN US4050241003
Description
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD78.20
-1.64 (-2.05%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
902.4K
Beta
0.54
Float Shares
45.80M
Free Float %
98.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.22% | -8.48% | -8.86% | -9.37% | -28.56% | -34.82% | -25.62% | -41.60% | -12.69% | +96.54% | +779.83% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (20 ratings, all time)
Buy
Price Targets & DCF
Current price
78.20
Low
67.00
-14.3%
Consensus
80.25
+2.6%
Median
80.00
+2.3%
High
94.00
+20.2%
DCF (Unlevered)
171.10
+118.8%
DCF (Levered)
178.85
+128.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
64% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 3 | 0 |
| Hold | 4 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
70.00
-10.5%
|
| Last Quarter | 1 |
70.00
-10.5%
|
| Last Year | 10 |
85.30
+9.1%
|
| All Time | 14 |
91.86
+17.5%
|
Quality scores
Altman Z-Score
2.08
Grey zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-2.0% Q1'26: +4.8% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-38.1% Q1'26: -137.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+25.4% ★ Q1'26: +15.4% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+18.1% ★ Q1'26: +14.4% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+9.8% ★ Q1'26: +8.0% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-6.7% ★ Q1'26: -6.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×3.08× Q1'26: 2.53× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2009 actual |
Mar 2010 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 8 Rev. Ana. 9 EPS Ana. |
Mar 2027 8 Rev. Ana. 8 EPS Ana. |
Mar 2028 8 Rev. Ana. 7 EPS Ana. |
Mar 2029 2 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
597.88M
est: 544.88M (+9.7%)
|
645.43M
est: 597.29M (+8.1%)
|
891.99M
est: 839.78M (+6.2%)
|
938.51M
est: 909.11M (+3.2%)
|
910.37M
est: 922.63M (-1.3%)
|
908.83M
est: 911.53M (-0.3%)
|
886.12M
est: 876.92M (+1.0%)
|
903.92M
est: 898.02M (+0.7%)
|
967.58M
est: 968.50M (-0.1%)
|
988.48M
est: 995.92M (-0.7%)
|
870.46M
est: 868.82M (+0.2%)
|
993.20M
est: 986.15M (+0.7%)
|
1.17B
est: 1.15B (+1.2%)
|
1.31B
est: 1.36B (-3.8%)
|
1.36B
est: 1.36B (+0.1%)
|
1.33B
1.32B – 1.34B
-2.5% YoY
|
1.40B
1.39B – 1.42B
+5.7% YoY
|
1.48B
1.47B – 1.50B
+5.3% YoY
|
1.55B
1.55B – 1.56B
+5.3% YoY
|
1.67B
1.66B – 1.69B
+7.6% YoY
|
| EBITDA |
121.53M
est: 117.35M (+3.6%)
|
125.25M
est: 127.64M (-1.9%)
|
124.58M
est: 116.21M (+7.2%)
|
127.04M
est: 116.53M (+9.0%)
|
125.72M
est: 132.30M (-5.0%)
|
128.74M
est: 60.23M (+113.7%)
|
123.25M
est: 110.20M (+11.8%)
|
153.03M
est: 44.53M (+243.7%)
|
192.96M
est: 158.99M (+21.4%)
|
257.93M
est: 167.87M (+53.6%)
|
184.38M
est: 194.87M (-5.4%)
|
191.72M
est: 139.53M (+37.4%)
|
252.01M
est: 216.00M (+16.7%)
|
295.45M
est: 553.93M (-46.7%)
|
355.99M
est: 553.26M (-35.7%)
|
539.33M
535.28M – 545.22M
-2.5% YoY
|
570.19M
564.73M – 576.42M
+5.7% YoY
|
600.57M
596.54M – 608.64M
+5.3% YoY
|
632.40M
629.11M – 635.68M
+5.3% YoY
|
680.24M
673.73M – 687.67M
+7.6% YoY
|
| EBIT |
85.07M
est: 81.23M (+4.7%)
|
82.01M
est: 92.02M (-10.9%)
|
60.68M
est: 60.76M (-0.1%)
|
48.19M
est: 47.95M (+0.5%)
|
43.06M
est: 43.37M (-0.7%)
|
43.73M
est: -25.88M (+268.9%)
|
39.21M
est: 21.82M (+79.7%)
|
64.16M
est: -19.68M (+426.0%)
|
83.55M
est: 68.91M (+21.2%)
|
165.75M
est: 80.63M (+105.6%)
|
100.10M
est: 114.30M (-12.4%)
|
105.17M
est: 30.54M (+244.4%)
|
167.20M
est: 106.90M (+56.4%)
|
206.84M
est: 363.14M (-43.0%)
|
247.10M
est: 362.70M (-31.9%)
|
353.56M
350.91M – 357.43M
-2.5% YoY
|
373.79M
370.21M – 377.88M
+5.7% YoY
|
393.71M
391.07M – 399.00M
+5.3% YoY
|
414.57M
412.42M – 416.73M
+5.3% YoY
|
445.94M
441.67M – 450.81M
+7.6% YoY
|
| Net Income |
59.30M
est: 54.72M (+8.4%)
|
58.38M
est: 64.71M (-9.8%)
|
38.80M
est: 45.19M (-14.1%)
|
35.15M
est: 34.24M (+2.7%)
|
16.90M
est: 31.62M (-46.6%)
|
-55.62M
est: -49.02M (-13.5%)
|
-26.27M
est: 6.41M (-509.6%)
|
45.57M
est: -18.51M (+346.2%)
|
55.02M
est: 44.80M (+22.8%)
|
76.53M
est: 63.70M (+20.1%)
|
79.47M
est: 89.59M (-11.3%)
|
43.38M
est: -3.10M (+1,498.8%)
|
115.40M
est: 128.28M (-10.0%)
|
117.56M
est: 115.40M (+1.9%)
|
167.68M
est: 214.96M (-22.0%)
|
234.33M
233.15M – 235.52M
+9.0% YoY
|
249.38M
243.53M – 255.24M
+6.4% YoY
|
273.67M
265.45M – 281.89M
+9.7% YoY
|
297.80M
293.84M – 301.77M
+8.8% YoY
|
357.52M
353.07M – 362.60M
+20.1% YoY
|
| SGA |
198.74M
est: 171.58M (+15.8%)
|
214.48M
est: 196.36M (+9.2%)
|
318.81M
est: 298.14M (+6.9%)
|
366.84M
est: 351.22M (+4.4%)
|
339.69M
est: 355.16M (-4.4%)
|
317.22M
est: 301.20M (+5.3%)
|
301.73M
est: 304.34M (-0.9%)
|
316.52M
est: 257.67M (+22.8%)
|
298.28M
est: 265.28M (+12.4%)
|
266.33M
est: 234.78M (+13.4%)
|
263.83M
est: 255.54M (+3.2%)
|
332.20M
est: 313.98M (+5.8%)
|
373.95M
est: 329.22M (+13.6%)
|
420.82M
est: 440.41M (-4.4%)
|
422.05M
est: 439.88M (-4.1%)
|
428.80M
425.58M – 433.49M
-2.5% YoY
|
453.34M
449.00M – 458.29M
+5.7% YoY
|
477.50M
474.29M – 483.91M
+5.3% YoY
|
502.80M
500.19M – 505.41M
+5.3% YoY
|
540.83M
535.66M – 546.74M
+7.6% YoY
|
| EPS |
1.17
est: 1.04 (+12.5%)
|
1.15
est: 1.25 (-8.0%)
|
0.76
est: 1.63 (-53.4%)
|
0.68
est: 2.01 (-66.2%)
|
0.33
est: 1.90 (-82.6%)
|
-1.09
est: 1.73 (-163.1%)
|
-0.51
est: 1.52 (-133.6%)
|
0.86
est: 1.87 (-53.9%)
|
1.07
est: 2.33 (-54.2%)
|
1.51
est: 3.34 (-54.8%)
|
1.57
est: 2.56 (-38.7%)
|
0.85
est: 2.53 (-66.4%)
|
2.27
est: 2.97 (-23.5%)
|
2.32
est: 2.43 (-4.7%)
|
3.31
est: 4.54 (-27.2%)
|
4.94
4.92 – 4.97
+8.8% YoY
|
5.24
5.14 – 5.39
+6.0% YoY
|
5.79
5.61 – 5.95
+10.5% YoY
|
6.28
6.21 – 6.37
+8.4% YoY
|
7.55
7.46 – 7.66
+20.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
253.77M
OE per share TTM
5.40
Owner's Yield
10.10%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
24.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
89
Total invested
232.83M
Insider transactions (90d)
1
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1) BlackRock, Inc. | 6.69M | 13.10% | 6.45M | — | 6.69M | — | HC | Delaware | 2022-01-27 | ↗ |
| 2 | Wellington Group Holdings LLP | 5.54M | 10.83% | — | 4.97M | — | — | HC | Delaware | 2022-02-10 | ↗ |
| 3 | Wellington Investment Advisors Holdings LLP | 5.54M | 10.83% | — | 4.97M | — | — | HC | Delaware | 2022-02-10 | ↗ |
| 4 | Wellington Management Group LLP | 5.54M | 10.83% | — | 4.97M | — | — | HC | Massachusetts | 2022-02-10 | ↗ |
| 5 | Wellington Management Company LLP | 5.29M | 10.35% | — | 4.84M | — | — | IA | Delaware | 2022-02-10 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 5.20M | 10.12% | — | 85.9K | 5.06M | 135.3K | IA | Pennsylvania | 2022-10-11 | ↗ |
| 7 | Neuberger Berman Group LLC | 3.88M | 7.59% | — | 3.73M | — | 3.88M | HC | — | 2022-02-14 | ↗ |
| 8 | Neuberger Berman Investment Advisers LLC | 3.88M | 7.59% | — | 3.73M | — | 3.88M | IA | — | 2022-02-14 | ↗ |
| 9 | 85-4328500 | 2.85M | 5.60% | 2.85M | — | 2.85M | — | IA | Maryland | 2024-11-14 | ↗ |
| 10 | Capital Research Global Investors ** | 2.69M | 5.30% | 2.69M | — | 2.69M | — | IA | — | 2020-02-14 | ↗ |
| 11 | 52-0556948 | 1.52M | 2.80% | 413.5K | — | 1.52M | — | IA | Maryland | 2018-02-14 | ↗ |
| 12 | 95-1411037 | 13.00 | 10.70% | 5.45M | — | 5.45M | — | IA | Delaware | 2022-04-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
89
-257 vs prev Q
New positions
13
Closed positions
256
Increased
46
Reduced
29
Put/Call ratio
0.00
Calls held
—
Puts held
400.00
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 5.82M -199.7K (-3.3%) | 466.55M +173.1M (+59.0%) | 12.44% -0.074 pp | 0.01% +0.003 pp | USD79.85 +0.4% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 4.76M -73.5K (-1.5%) | 381.60M +146.0M (+61.9%) | 10.18% +0.126 pp | 0.01% +0.002 pp | USD47.59 +68.4% | 84 qtrs — |
| 3 | NEUBERGER BERMAN GROUP LLC | 3.87M +195.4K (+5.3%) | 309.88M +131.0M (+73.2%) | 8.26% +0.633 pp | 0.23% +0.100 pp | USD73.87 +8.5% | 61 qtrs — |
| 4 | AQR CAPITAL MANAGEMENT LLC | 3.16M +1.0M (+48.6%) | 253.52M +150.7M (+146.6%) | 6.76% +2.335 pp | 0.13% +0.067 pp | USD62.21 +28.8% | 39 qtrs — |
| 5 | STATE STREET CORP | 1.73M -70.9K (-3.9%) | 138.65M +50.9M (+58.0%) | 3.70% -0.046 pp | 0.00% +0.002 pp | USD62.48 +28.3% | 51 qtrs — |
| 6 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.38M +1.3M (+994.7%) | 110.62M +104.5M (+1,700.2%) | 2.95% +2.687 pp | 0.06% +0.061 pp | USD77.28 +3.7% | 2 qtrs — |
| 7 | FMR LLC | 1.33M +111.1K (+9.1%) | 106.35M +47.1M (+79.5%) | 2.84% +0.309 pp | 0.01% +0.002 pp | USD70.33 +14.0% | 54 qtrs — |
| 8 | CITADEL ADVISORS LLC | 1.29M +1.1M (+481.9%) | 103.27M +92.5M (+856.9%) | 2.75% +2.293 pp | 0.02% +0.014 pp | USD78.96 +1.5% | 33 qtrs — |
| 9 | HOLOCENE ADVISORS, LP | 1.26M +1.2M (+3,148.4%) | 101.33M +99.4M (+5,241.8%) | 2.70% +2.621 pp | 0.21% +0.209 pp | USD79.18 +1.2% | 8 qtrs — |
| 10 | GOLDMAN SACHS GROUP INC | 1.23M +643.9K (+110.5%) | 98.31M +69.9M (+246.1%) | 2.62% +1.410 pp | 0.01% +0.009 pp | USD79.90 +0.3% | 73 qtrs — |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 1.19M -8.8K (-0.7%) | 95.76M +37.1M (+63.2%) | 2.55% +0.052 pp | 0.01% +0.002 pp | USD70.76 +13.3% | 78 qtrs — |
| 12 | NORTH PEAK CAPITAL MANAGEMENT, LLC | 1.10M +740.6K (+204.4%) | 88.40M +70.7M (+400.5%) | 2.36% +1.604 pp | 7.51% +5.965 pp | USD69.83 +14.8% | 2 qtrs — |
| 13 | RIVER ROAD ASSET MANAGEMENT, LLC | 1.10M -552.7K (-33.4%) | 88.34M +7.7M (+9.5%) | 2.36% -1.084 pp | 0.97% +0.065 pp | USD65.29 +22.8% | 4 qtrs — |
| 14 | DIMENSIONAL FUND ADVISORS LP | 1.09M -6.6K (-0.6%) | 87.60M +34.0M (+63.5%) | 2.34% +0.050 pp | 0.02% +0.007 pp | USD63.10 +27.0% | 51 qtrs — |
| 15 | ROYAL BANK OF CANADA | 967.6K -293.2K (-23.3%) | 77.55M +16.1M (+26.2%) | 2.07% -0.553 pp | 0.01% +0.003 pp | USD76.80 +4.4% | 51 qtrs — |
| 16 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 943.2K -67.8K (-6.7%) | 75.60M +26.3M (+53.4%) | 2.02% -0.086 pp | 0.05% +0.018 pp | USD84.10 -4.7% | 10 qtrs — |
| 17 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 939.7K -121.1K (-11.4%) | 75.16M +23.4M (+45.2%) | 2.01% -0.197 pp | 0.12% +0.039 pp | USD70.85 +13.1% | 17 qtrs — |
| 18 | POINT72 ASSET MANAGEMENT, L.P. | 853.4K +810.3K (+1,882.3%) | 68.40M +66.3M (+3,159.7%) | 1.82% +1.734 pp | 0.08% +0.073 pp | USD79.33 +1.0% | 4 qtrs — |
| 19 | FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 717.0K +10.7K (+1.5%) | 57.47M +23.0M (+66.9%) | 1.53% +0.064 pp | 0.31% +0.120 pp | USD67.50 +18.7% | 8 qtrs — |
| 20 | BOSTON TRUST WALDEN CORP | 580.7K -376.0K (-39.3%) | 46.54M -90.0K (-0.2%) | 1.24% -0.748 pp | 0.35% +0.009 pp | USD69.25 +15.7% | 51 qtrs — |
| 21 | NORTHERN TRUST CORP | 577.7K -24.7K (-4.1%) | 46.30M +16.9M (+57.7%) | 1.23% -0.017 pp | 0.01% +0.002 pp | USD62.08 +29.1% | 51 qtrs — |
| 22 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 573.7K -68.0K (-10.6%) | 45.98M +14.7M (+47.0%) | 1.23% -0.108 pp | 0.32% +0.109 pp | USD80.75 -0.7% | 8 qtrs — |
| 23 | MORGAN STANLEY | 562.9K +42.1K (+8.1%) | 45.12M +19.7M (+77.8%) | 1.20% +0.121 pp | 0.00% +0.001 pp | USD77.13 +3.9% | 51 qtrs — |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 548.9K -12.9K (-2.3%) | 44.00M +16.6M (+60.7%) | 1.17% +0.005 pp | 0.01% +0.003 pp | USD59.28 +35.2% | 100 qtrs — |
| 25 | UBS GROUP AG | 539.7K -912.9K (-62.8%) | 43.26M -27.5M (-38.9%) | 1.15% -1.866 pp | 0.01% -0.004 pp | USD63.04 +27.1% | 45 qtrs — |
| 26 | JANE STREET GROUP, LLC | 526.3K +242.5K (+85.5%) | 42.18M +28.4M (+205.0%) | 1.12% +0.535 pp | 0.01% +0.004 pp | USD63.81 +25.6% | 28 qtrs — |
| 27 | BARROW HANLEY MEWHINNEY & STRAUSS LLC | 523.1K -36.9K (-6.6%) | 41.93M +14.6M (+53.6%) | 1.12% -0.046 pp | 0.14% +0.053 pp | USD70.95 +13.0% | 3 qtrs — |
| 28 | BANK OF AMERICA CORP /DE/ | 482.2K +147.9K (+44.2%) | 38.65M +22.4M (+137.2%) | 1.03% +0.336 pp | 0.00% +0.002 pp | USD77.53 +3.4% | 52 qtrs — |
| 29 | FRANKLIN RESOURCES INC | 464.1K -163.1K (-26.0%) | 37.20M +6.6M (+21.7%) | 0.99% -0.312 pp | 0.01% +0.002 pp | USD70.68 +13.4% | 51 qtrs — |
| 30 | MARSHALL WACE, LLP | 433.0K -30.9K (-6.7%) | 34.70M +12.1M (+53.5%) | 0.93% -0.039 pp | 0.03% +0.009 pp | USD70.94 +13.0% | 11 qtrs — |
| 31 | DEUTSCHE BANK AG\ | 401.8K +112.2K (+38.8%) | 32.20M +18.1M (+128.2%) | 0.86% +0.257 pp | 0.01% +0.006 pp | USD81.54 -1.7% | 50 qtrs — |
| 32 | ARISTOTLE CAPITAL BOSTON, LLC | 370.3K -33.9K (-8.4%) | 29.68M +10.0M (+50.7%) | 0.79% -0.049 pp | 1.63% +0.614 pp | USD79.39 +1.0% | 22 qtrs — |
| 33 | PRICE T ROWE ASSOCIATES INC /MD/ | 359.2K -3.5K (-1.0%) | 28.79M +11.1M (+62.8%) | 0.77% +0.014 pp | 0.00% +0.001 pp | USD76.97 +4.1% | 75 qtrs — |
| 34 | BOSTON PARTNERS | 322.7K -248.2K (-43.5%) | 25.77M -2.2M (-8.0%) | 0.69% -0.497 pp | 0.03% -0.002 pp | USD74.70 +7.3% | 19 qtrs — |
| 35 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 314.7K -162.1K (-34.0%) | 25.22M +2.0M (+8.5%) | 0.67% -0.318 pp | 0.07% +0.010 pp | USD76.11 +5.3% | 6 qtrs — |
| 36 | BANK OF NEW YORK MELLON CORP | 305.2K -44.9K (-12.8%) | 24.46M +7.4M (+43.4%) | 0.65% -0.075 pp | 0.00% +0.001 pp | USD52.88 +51.6% | 66 qtrs — |
| 37 | MIZUHO MARKETS AMERICAS LLC | 278.3K +146.0K (+110.3%) | 22.31M +15.9M (+245.9%) | 0.59% +0.320 pp | 0.43% +0.310 pp | USD81.35 -1.5% | 7 qtrs — |
| 38 | LONDON CO OF VIRGINIA | 263.6K -2.5K (-0.9%) | 21.13M +8.2M (+62.9%) | 0.56% +0.010 pp | 0.12% +0.050 pp | USD98.94 -19.0% | 21 qtrs — |
| 39 | JPMORGAN CHASE & CO | 256.6K -22.4K (-8.0%) | 20.56M +7.0M (+51.2%) | 0.55% -0.032 pp | 0.00% +0.001 pp | USD70.81 +13.2% | 41 qtrs — |
| 40 | NUVEEN, LLC | 234.6K +101.3K (+76.0%) | 18.80M +12.3M (+189.4%) | 0.50% +0.224 pp | 0.00% +0.003 pp | USD70.72 +13.3% | 4 qtrs — |
| 41 | WELLINGTON MANAGEMENT GROUP LLP | 225.6K -91.5K (-28.9%) | 18.08M +2.6M (+17.0%) | 0.48% -0.177 pp | 0.00% +0.001 pp | USD73.86 +8.5% | 63 qtrs — |
| 42 | CITIGROUP INC | 220.0K +220.0K (+100.0%) | 17.63M +17.6M (+100.0%) | 0.47% +0.470 pp | 0.01% +0.008 pp | USD80.15 +0.0% | 1 qtrs NEW |
| 43 | JANUS HENDERSON GROUP PLC | 186.7K +164.3K (+731.5%) | 14.97M +13.9M (+1,267.7%) | 0.40% +0.352 pp | 0.01% +0.006 pp | USD80.06 +0.1% | 19 qtrs — |
| 44 | INVESCO LTD. | 168.7K +4.8K (+2.9%) | 13.52M +5.5M (+69.3%) | 0.36% +0.020 pp | 0.00% +0.001 pp | USD71.99 +11.3% | 57 qtrs — |
| 45 | RAYMOND JAMES FINANCIAL INC | 168.3K -156.0K (-48.1%) | 13.49M -2.3M (-14.6%) | 0.36% -0.314 pp | 0.00% -0.001 pp | USD70.48 +13.7% | 5 qtrs — |
| 46 | SEI INVESTMENTS CO | 167.4K -248.0 (-0.1%) | 13.41M +5.2M (+64.2%) | 0.36% +0.009 pp | 0.01% +0.005 pp | USD78.40 +2.2% | 45 qtrs — |
| 47 | PRINCIPAL FINANCIAL GROUP INC | 163.8K +15.5K (+10.4%) | 13.13M +5.9M (+81.6%) | 0.35% +0.042 pp | 0.01% +0.003 pp | USD77.27 +3.7% | 81 qtrs — |
| 48 | LOOMIS SAYLES & CO L P | 154.2K -70.1K (-31.2%) | 12.36M +1.4M (+13.1%) | 0.33% -0.137 pp | 0.01% +0.002 pp | USD78.31 +2.3% | 8 qtrs — |
| 49 | RHUMBLINE ADVISERS | 140.4K -16.5K (-10.5%) | 11.25M +3.6M (+47.2%) | 0.30% -0.026 pp | 0.01% +0.003 pp | USD66.92 +19.8% | 55 qtrs — |
| 50 | QUBE RESEARCH & TECHNOLOGIES LTD | 135.8K -134.6K (-49.8%) | 10.88M -2.3M (-17.4%) | 0.29% -0.272 pp | 0.01% -0.003 pp | USD48.74 +64.4% | 15 qtrs — |
| 51 | UBS ASSET MANAGEMENT AMERICAS INC | 131.6K -407.0 (-0.3%) | 10.54M +4.1M (+63.9%) | 0.28% +0.007 pp | 0.00% +0.001 pp | USD83.20 -3.7% | 52 qtrs — |
| 52 | D. E. SHAW & CO., INC. | 131.5K +131.5K (+100.0%) | 10.54M +10.5M (+100.0%) | 0.28% +0.281 pp | 0.01% +0.006 pp | USD80.15 +0.0% | 1 qtrs NEW |
| 53 | NORGES BANK | 125.9K +125.9K (+100.0%) | 10.09M +10.1M (+100.0%) | 0.27% +0.269 pp | 0.00% +0.001 pp | USD80.15 +0.0% | 1 qtrs NEW |
| 54 | TREXQUANT INVESTMENT LP | 125.5K +15.9K (+14.5%) | 10.06M +4.7M (+88.3%) | 0.27% +0.040 pp | 0.09% +0.035 pp | USD63.03 +27.2% | 3 qtrs — |
| 55 | BARCLAYS PLC | 124.2K +21.7K (+21.2%) | 9.96M +1.7M (+20.8%) | 0.27% +0.052 pp | 0.00% +0.000 pp | USD76.55 +4.7% | 51 qtrs — |
| 56 | HRT FINANCIAL LP | 115.9K +80.2K (+225.2%) | 9.29M +7.6M (+434.9%) | 0.25% +0.174 pp | 0.03% +0.023 pp | USD70.49 +13.7% | 4 qtrs — |
| 57 | PEAK6 LLC | 108.2K +108.2K (+100.0%) | 8.67M +8.7M (+100.0%) | 0.23% +0.231 pp | 0.02% +0.016 pp | USD80.15 +0.0% | 1 qtrs NEW |
| 58 | KESTREL INVESTMENT MANAGEMENT CORP | 98.1K -3.7K (-3.6%) | 7.86M +2.9M (+58.5%) | 0.21% -0.002 pp | 4.46% +1.660 pp | USD48.74 +64.4% | 2 qtrs — |
| 59 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 96.3K -215.5K (-69.1%) | 7.72M -7.5M (-49.2%) | 0.21% -0.442 pp | 0.06% -0.095 pp | USD57.77 +38.7% | 7 qtrs — |
| 60 | NORDEA INVESTMENT MANAGEMENT AB | 95.3K -12.6K (-11.7%) | 7.62M +2.5M (+48.2%) | 0.20% -0.021 pp | 0.01% +0.002 pp | USD79.57 +0.7% | 23 qtrs — |
| 61 | SWISS NATIONAL BANK | 95.0K +1.9K (+2.0%) | 7.61M +3.1M (+67.8%) | 0.20% +0.010 pp | 0.00% +0.002 pp | USD55.23 +45.1% | 51 qtrs — |
| 62 | SIO CAPITAL MANAGEMENT, LLC | 92.6K -105.4K (-53.2%) | 7.42M -2.2M (-23.1%) | 0.20% -0.214 pp | 1.17% -1.275 pp | USD48.74 +64.4% | 4 qtrs — |
| 63 | STEADFAST CAPITAL MANAGEMENT LP | 91.8K +91.8K (+100.0%) | 7.36M +7.4M (+100.0%) | 0.20% +0.196 pp | 0.13% +0.126 pp | USD80.15 +0.0% | 1 qtrs NEW |
| 64 | ALLIANCEBERNSTEIN L.P. | 91.7K -3.3K (-3.4%) | 7.35M +2.7M (+58.8%) | 0.20% -0.001 pp | 0.00% +0.001 pp | USD71.27 +12.5% | 61 qtrs — |
| 65 | WELLS FARGO & COMPANY/MN | 91.1K +39.3K (+75.7%) | 7.30M +4.8M (+189.0%) | 0.19% +0.087 pp | 0.00% +0.001 pp | USD77.82 +3.0% | 57 qtrs — |
| 66 | CAMPBELL & CO INVESTMENT ADVISER LLC | 86.9K +80.0K (+1,167.3%) | 6.96M +6.6M (+1,983.9%) | 0.19% +0.172 pp | 0.33% +0.309 pp | USD77.67 +3.2% | 15 qtrs — |
| 67 | ALGERT GLOBAL LLC | 77.0K +77.0K (+100.0%) | 6.17M +6.2M (+100.0%) | 0.16% +0.165 pp | 0.10% +0.096 pp | USD80.15 +0.0% | 3 qtrs — |
| 68 | ASSENAGON ASSET MANAGEMENT S.A. | 76.5K -99.1K (-56.4%) | 6.13M -2.4M (-28.4%) | 0.16% -0.202 pp | 0.01% -0.003 pp | USD48.74 +64.4% | 2 qtrs — |
| 69 | LEGAL & GENERAL GROUP PLC | 75.9K -5.8K (-7.1%) | 6.09M +2.1M (+52.8%) | 0.16% -0.008 pp | 0.00% +0.001 pp | USD76.05 +5.4% | 46 qtrs — |
| 70 | HEARTLAND ADVISORS INC | 75.0K -21.1K (-22.0%) | 6.01M +1.3M (+28.3%) | 0.16% -0.040 pp | 0.32% +0.076 pp | USD64.35 +24.6% | 19 qtrs — |
| 71 | AMERICAN CAPITAL MANAGEMENT INC | 74.4K +— (+0.0%) | 5.96M +2.3M (+64.4%) | 0.16% +0.004 pp | 0.26% +0.119 pp | USD42.03 +90.7% | 54 qtrs — |
| 72 | ROYCE & ASSOCIATES LP | 71.5K -629.8K (-89.8%) | 5.73M -28.4M (-83.2%) | 0.15% -1.305 pp | 0.06% -0.283 pp | USD80.80 -0.8% | 25 qtrs — |
| 73 | WALLEYE TRADING LLC | 71.2K -6.8K (-8.7%) | 5.71M +1.9M (+50.1%) | 0.15% -0.010 pp | 0.01% +0.002 pp | USD77.02 +4.1% | 7 qtrs — |
| 74 | AMERICAN CENTURY COMPANIES INC | 69.8K +8.2K (+13.3%) | 5.60M +2.6M (+86.3%) | 0.15% +0.021 pp | 0.00% +0.001 pp | USD57.30 +39.9% | 20 qtrs — |
| 75 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 69.4K +33.6K (+93.8%) | 5.56M +3.8M (+218.7%) | 0.15% +0.074 pp | 0.00% +0.000 pp | USD74.68 +7.3% | 37 qtrs — |
| 76 | BNP PARIBAS ARBITRAGE, SNC | 68.0K +51.7K (+315.9%) | 5.45M +4.7M (+583.9%) | 0.15% +0.111 pp | 0.00% +0.002 pp | USD79.95 +0.3% | 51 qtrs — |
| 77 | ISTHMUS PARTNERS, LLC | 67.6K +5.9K (+9.6%) | 5.42M +2.4M (+80.2%) | 0.14% +0.016 pp | 0.60% -0.065 pp | USD74.58 +7.5% | 9 qtrs — |
| 78 | AMERIPRISE FINANCIAL INC | 65.5K -11.9K (-15.3%) | 5.25M +1.5M (+39.2%) | 0.14% -0.021 pp | 0.00% +0.000 pp | USD71.50 +12.1% | 56 qtrs — |
| 79 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 65.1K +65.1K (+100.0%) | 5.22M +5.2M (+100.0%) | 0.14% +0.139 pp | 0.01% +0.006 pp | USD80.15 +0.0% | 3 qtrs — |
| 80 | SCHWARTZ INVESTMENT COUNSEL INC | 65.0K -72.3K (-52.6%) | 5.21M -1.5M (-22.1%) | 0.14% -0.146 pp | 0.18% -0.042 pp | USD68.25 +17.4% | 23 qtrs — |
| 81 | RUSSELL INVESTMENTS GROUP, LTD. | 61.6K +5.6K (+10.0%) | 4.94M +2.2M (+80.9%) | 0.13% +0.015 pp | 0.01% +0.002 pp | USD65.11 +23.1% | 37 qtrs — |
| 82 | WALLEYE CAPITAL LLC | 59.9K -100.0K (-62.5%) | 4.80M -3.0M (-38.4%) | 0.13% -0.204 pp | 0.01% -0.015 pp | USD70.55 +13.6% | 7 qtrs — |
| 83 | RETIREMENT SYSTEMS OF ALABAMA | 56.2K -2.1K (-3.6%) | 4.50M +1.7M (+58.6%) | 0.12% -0.001 pp | 0.01% +0.005 pp | USD82.38 -2.7% | 31 qtrs — |
| 84 | NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 55.9K +6.0K (+12.1%) | 4.48M +2.1M (+84.4%) | 0.12% +0.016 pp | 0.01% +0.004 pp | USD51.86 +54.6% | 51 qtrs — |
| 85 | RICE HALL JAMES & ASSOCIATES, LLC | 55.0K +2.0K (+3.9%) | 4.41M +1.8M (+70.8%) | 0.12% +0.008 pp | 0.24% +0.102 pp | USD69.78 +14.9% | 18 qtrs — |
| 86 | MILLENNIUM MANAGEMENT LLC | 54.8K -718.4K (-92.9%) | 4.39M -33.3M (-88.3%) | 0.12% -1.490 pp | 0.00% -0.014 pp | USD50.39 +59.1% | 55 qtrs — |
| 87 | STATE OF WISCONSIN INVESTMENT BOARD | 52.2K -17.9K (-25.5%) | 4.18M +768.0K (+22.5%) | 0.11% -0.034 pp | 0.01% +0.002 pp | USD78.29 +2.4% | 26 qtrs — |
| 88 | METLIFE INVESTMENT MANAGEMENT, LLC | 49.2K -3.2K (-6.2%) | 3.94M +1.4M (+54.3%) | 0.11% -0.004 pp | 0.02% +0.007 pp | USD65.30 +22.7% | 33 qtrs — |
| 89 | CASTLEARK MANAGEMENT LLC | 48.3K +48.3K (+100.0%) | 3.87M +3.9M (+100.0%) | 0.10% +0.103 pp | 0.11% +0.114 pp | USD80.15 +0.0% | 1 qtrs NEW |
| 90 | COMERICA BANK | 46.6K +10.8K (+30.3%) | 3.74M +2.0M (+114.2%) | 0.10% +0.025 pp | 0.01% +0.008 pp | USD81.16 -1.2% | 11 qtrs — |
| 91 | PRUDENTIAL FINANCIAL INC | 46.1K +38.8K (+529.6%) | 3.70M +3.3M (+935.3%) | 0.10% +0.083 pp | 0.00% +0.004 pp | USD79.20 +1.2% | 85 qtrs — |
| 92 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 46.1K -165.5K (-78.2%) | 3.70M -6.6M (-64.2%) | 0.10% -0.341 pp | 0.00% -0.005 pp | USD75.99 +5.5% | 51 qtrs — |
| 93 | TUDOR INVESTMENT CORP ET AL | 45.8K +45.8K (+100.0%) | 3.67M +3.7M (+100.0%) | 0.10% +0.098 pp | 0.01% +0.007 pp | USD80.15 +0.0% | 1 qtrs NEW |
| 94 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 45.7K -1.6K (-3.4%) | 3.66M +1.4M (+58.9%) | 0.10% -0.001 pp | 0.00% +0.001 pp | USD51.15 +56.7% | 52 qtrs — |
| 95 | MAY HILL CAPITAL, LLC | 44.7K +22.3K (+100.0%) | 3.58M +2.5M (+228.9%) | 0.10% +0.049 pp | 0.47% +0.149 pp | USD76.20 +5.2% | 5 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
3.00
Bullish
Buys
1
Sells
1
Shares acquired
1.4K
Shares disposed
145.00
Cash buys
1.00
Cash sales
—
Net activity
+1,255
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | DArecca James | Officer | F-InKind | D | Common Stock | 655 | 59.26 | 38.8K | 27,637 | D | ↗ |
| 2025-11-10 | KROLL MARK W | Director | P-Purchase | A | Common Stock | 1,400 | 70.56 | 98.8K | 24,757 | D | ↗ |
| 2025-10-31 | Galvin Roy | Officer | F-InKind | D | Common Stock | 145 | 50.01 | 7.3K | 12,811 | D | ↗ |
| 2025-09-17 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 238 | 49.95 | 11.9K | 28,925 | D | ↗ |
| 2025-07-24 | Zane Ellen M | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 19,373 | D | ↗ |
| 2025-07-24 | Pomeroy Claire | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 16,872 | D | ↗ |
| 2025-07-24 | KROLL MARK W | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 23,357 | D | ↗ |
| 2025-07-24 | Johnson Lloyd Emerson | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 12,933 | D | ↗ |
| 2025-07-24 | Dockendorff Charles J | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 7,126 | D | ↗ |
| 2025-07-24 | COYLE MICHAEL J | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 15,394 | D | ↗ |
| 2025-07-24 | Bryant Diane M | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 7,126 | D | ↗ |
| 2025-07-24 | ABERNATHY ROBERT E | Director | A-Award | A | Common Stock | 2,693 | 0.00 | — | 24,981 | D | ↗ |
| 2025-06-05 | Miller Laurie A. | Officer | A-Award | A | Common Stock | 3,195 | 0.00 | — | 29,163 | D | ↗ |
| 2025-06-05 | Maunsell Farris Maryanne | Officer | A-Award | A | Common Stock | 2,662 | 0.00 | — | 4,478 | D | ↗ |
| 2025-05-30 | Simon, Christopher | Director / Officer | A-Award | A | Common Stock | 66,666 | 0.00 | — | 401,778 | D | ↗ |
| 2025-05-30 | Miller Laurie A. | Officer | A-Award | A | Common Stock | 7,777 | 0.00 | — | 28,251 | D | ↗ |
| 2025-05-30 | DArecca James | Officer | F-InKind | D | Common Stock | 5,864 | 69.38 | 406.8K | 28,292 | D | ↗ |
| 2025-05-30 | Basil Michelle L | Officer | A-Award | A | Common Stock | 15,554 | 0.00 | — | 49,721 | D | ↗ |
| 2025-05-16 | Simon, Christopher | Director / Officer | A-Award | A | Common Stock | 21,405 | 0.00 | — | 335,112 | D | ↗ |
| 2025-05-16 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 477 | 70.31 | 33.5K | 17,274 | D | ↗ |
| 2025-05-16 | Maunsell Farris Maryanne | Officer | F-InKind | D | Common Stock | 68 | 70.31 | 4.8K | 1,016 | D | ↗ |
| 2025-05-16 | Galvin Roy | Officer | F-InKind | D | Common Stock | 257 | 70.31 | 18.1K | 7,243 | D | ↗ |
| 2025-05-16 | DArecca James | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 15,396 | 70.31 | 1.08M | 15,396 | D | ↗ |
| 2025-05-16 | Chan Frank | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 12,317 | 70.31 | 866.0K | 12,317 | D | ↗ |
| 2025-05-16 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 2,157 | 70.31 | 151.7K | 28,478 | D | ↗ |
| 2025-05-15 | Simon, Christopher | Director / Officer | F-InKind | D | Common Stock | 2,391 | 69.38 | 165.9K | 320,796 | D | ↗ |
| 2025-05-15 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 206 | 69.38 | 14.3K | 17,751 | D | ↗ |
| 2025-05-15 | Maunsell Farris Maryanne | Officer | F-InKind | D | Common Stock | 60 | 69.38 | 4.2K | 1,084 | D | ↗ |
| 2025-05-15 | Galvin Roy | Officer | F-InKind | D | Common Stock | 201 | 69.38 | 13.9K | 7,500 | D | ↗ |
| 2025-05-15 | DArecca James | Officer | F-InKind | D | Common Stock | 622 | 69.38 | 43.2K | 16,070 | D | ↗ |
| 2025-05-15 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 622 | 69.38 | 43.2K | 30,635 | D | ↗ |
| 2025-05-02 | DArecca James | Officer | F-InKind | D | Common Stock | 654 | 63.85 | 41.8K | 16,692 | D | ↗ |
| 2025-04-07 | Chan Frank | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-11-01 | Galvin Roy | Officer | F-InKind | D | Common Stock | 161 | 71.48 | 11.5K | 7,373 | D | ↗ |
| 2024-09-17 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 238 | 76.54 | 18.2K | 17,807 | — | ↗ |
| 2024-08-29 | Simon, Christopher | Director / Officer | J-Other | D | Common Stock | 39,704 | 75.56 | 3.00M | 322,838 | — | ↗ |
| 2024-07-26 | Strong Stewart W | Officer | S-Sale | D | Common Stock | 4,312 | 91.15 | 393.0K | 18,196 | — | ↗ |
| 2024-07-25 | Zane Ellen M | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 16,680 | — | ↗ |
| 2024-07-25 | Strong Stewart W | Officer | F-InKind | D | Common Stock | 2,798 | 90.58 | 253.4K | 22,508 | — | ↗ |
| 2024-07-25 | Pomeroy Claire | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 14,179 | — | ↗ |
| 2024-07-25 | KROLL MARK W | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 20,664 | — | ↗ |
| 2024-07-25 | Johnson Lloyd Emerson | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 10,240 | — | ↗ |
| 2024-07-25 | Dockendorff Charles J | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 4,433 | — | ↗ |
| 2024-07-25 | COYLE MICHAEL J | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 12,701 | — | ↗ |
| 2024-07-25 | Bryant Diane M | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 4,433 | — | ↗ |
| 2024-07-25 | ABERNATHY ROBERT E | Director | A-Award | A | Common Stock | 2,207 | 0.00 | — | 22,288 | — | ↗ |
| 2024-07-24 | Strong Stewart W | Officer | A-Award | A | Common Stock | 7,110 | 0.00 | — | 25,306 | — | ↗ |
| 2024-07-12 | Lingamneni Anila | Officer | S-Sale | D | Common Stock | 79 | 90.00 | 7.1K | 21,331 | — | ↗ |
| 2024-07-11 | Lingamneni Anila | Officer | S-Sale | D | Common Stock | 2,136 | 90.00 | 192.2K | 21,410 | — | ↗ |
| 2024-06-06 | Simon, Christopher | Director / Officer | M-Exempt | D | Non-qualified Stock Option (Right to Buy) | 104,516 | 41.64 | 4.35M | 0 | — | ↗ |
| 2024-05-29 | Strong Stewart W | Officer | S-Sale | D | Common Stock | 8,857 | 87.53 | 775.3K | 18,196 | — | ↗ |
| 2024-05-29 | Basil Michelle L | Officer | S-Sale | D | Common Stock | 8,896 | 87.86 | 781.6K | 35,351 | — | ↗ |
| 2024-05-28 | Strong Stewart W | Officer | A-Award | A | Common Stock | 13,256 | 0.00 | — | 31,452 | — | ↗ |
| 2024-05-28 | Simon, Christopher | Director / Officer | A-Award | A | Common Stock | 106,062 | 0.00 | — | 371,097 | — | ↗ |
| 2024-05-28 | Miller Laurie A. | Officer | A-Award | A | Common Stock | 2,650 | 0.00 | — | 18,823 | — | ↗ |
| 2024-05-28 | Llorens Josep | Officer | A-Award | A | Common Stock | 14,140 | 0.00 | — | 35,450 | — | ↗ |
| 2024-05-28 | Lingamneni Anila | Officer | F-InKind | D | Common Stock | 5,279 | 95.73 | 505.4K | 23,546 | — | ↗ |
| 2024-05-28 | Basil Michelle L | Officer | A-Award | A | Common Stock | 24,748 | 0.00 | — | 56,005 | — | ↗ |
| 2024-05-20 | Strong Stewart W | Officer | F-InKind | D | Common Stock | 1,555 | 95.08 | 147.8K | 18,882 | — | ↗ |
| 2024-05-20 | Llorens Josep | Officer | S-Sale | D | Common Stock | 987 | 95.08 | 93.8K | 21,310 | — | ↗ |
| 2024-05-20 | Basil Michelle L | Officer | S-Sale | D | Common Stock | 1,604 | 95.08 | 152.5K | 31,257 | — | ↗ |
| 2024-05-17 | Strong Stewart W | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 6,313 | 95.73 | 604.3K | 6,313 | — | ↗ |
| 2024-05-17 | Simon, Christopher | Director / Officer | A-Award | A | Common Stock | 14,624 | 0.00 | — | 265,035 | — | ↗ |
| 2024-05-17 | Miller Laurie A. | Officer | A-Award | A | Common Stock | 2,089 | 0.00 | — | 16,173 | — | ↗ |
| 2024-05-17 | Maunsell Farris Maryanne | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 1,291 | 95.73 | 123.6K | 1,291 | — | ↗ |
| 2024-05-17 | Llorens Josep | Officer | S-Sale | D | Common Stock | 822 | 94.82 | 77.9K | 16,350 | — | ↗ |
| 2024-05-17 | Lingamneni Anila | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 7,461 | 95.73 | 714.2K | 7,461 | — | ↗ |
| 2024-05-17 | Galvin Roy | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 6,313 | 95.73 | 604.3K | 6,313 | — | ↗ |
| 2024-05-17 | DArecca James | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 9,756 | 95.73 | 933.9K | 9,756 | — | ↗ |
| 2024-05-17 | Basil Michelle L | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 9,183 | 95.73 | 879.1K | 9,183 | — | ↗ |
| 2024-05-16 | Strong Stewart W | Officer | F-InKind | D | Common Stock | 1,677 | 96.14 | 161.2K | 16,341 | — | ↗ |
| 2024-05-16 | Simon, Christopher | Director / Officer | F-InKind | D | Common Stock | 1,907 | 94.80 | 180.8K | 254,448 | — | ↗ |
| 2024-05-16 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 233 | 94.80 | 22.1K | 14,160 | — | ↗ |
| 2024-05-16 | Llorens Josep | Officer | F-InKind | D | Common Stock | 263 | 94.80 | 24.9K | 17,942 | — | ↗ |
| 2024-05-16 | Lingamneni Anila | Officer | F-InKind | D | Common Stock | 318 | 94.80 | 30.1K | 11,640 | — | ↗ |
| 2024-05-16 | DArecca James | Officer | F-InKind | D | Common Stock | 351 | 94.80 | 33.3K | 12,907 | — | ↗ |
| 2024-05-16 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 446 | 94.80 | 42.3K | 31,410 | — | ↗ |
| 2024-05-15 | Strong Stewart W | Officer | F-InKind | D | Common Stock | 241 | 96.49 | 23.3K | 15,860 | — | ↗ |
| 2024-05-15 | Simon, Christopher | Director / Officer | F-InKind | D | Common Stock | 1,480 | 96.49 | 142.8K | 256,355 | — | ↗ |
| 2024-05-15 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 233 | 96.49 | 22.5K | 14,393 | — | ↗ |
| 2024-05-15 | Maunsell Farris Maryanne | Officer | F-InKind | D | Common Stock | 73 | 96.49 | 7.0K | 557 | — | ↗ |
| 2024-05-15 | Llorens Josep | Officer | F-InKind | D | Common Stock | 258 | 96.49 | 24.9K | 18,205 | — | ↗ |
| 2024-05-15 | Lingamneni Anila | Officer | F-InKind | D | Common Stock | 337 | 96.49 | 32.5K | 11,958 | — | ↗ |
| 2024-05-15 | Galvin Roy | Officer | F-InKind | D | Common Stock | 214 | 96.49 | 20.6K | 4,538 | — | ↗ |
| 2024-05-15 | DArecca James | Officer | F-InKind | D | Common Stock | 412 | 96.49 | 39.8K | 13,258 | — | ↗ |
| 2024-05-15 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 416 | 96.49 | 40.1K | 31,856 | — | ↗ |
| 2024-05-06 | Lingamneni Anila | Officer | S-Sale | D | Common Stock | 2,305 | 95.00 | 219.0K | 12,295 | — | ↗ |
| 2024-05-02 | DArecca James | Officer | F-InKind | D | Common Stock | 432 | 93.33 | 40.3K | 13,670 | — | ↗ |
| 2024-04-15 | Lingamneni Anila | Officer | F-InKind | D | Common Stock | 184 | 84.88 | 15.6K | 14,311 | — | ↗ |
| 2024-03-11 | Simon, Christopher | Director / Officer | G-Gift | D | Common Stock | 38,900 | 0.00 | — | 257,546 | — | ↗ |
| 2023-11-01 | Galvin Roy | Officer | F-InKind | D | Common Stock | 160 | 86.39 | 13.8K | 4,595 | — | ↗ |
| 2023-10-20 | Strong Stewart W | Officer | F-InKind | D | Common Stock | 120 | 89.05 | 10.7K | 16,101 | — | ↗ |
| 2023-10-20 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 197 | 89.05 | 17.5K | 32,272 | — | ↗ |
| 2023-09-15 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 209 | 90.11 | 18.8K | 14,363 | — | ↗ |
| 2023-09-12 | Strong Stewart W | Officer | S-Sale | D | Common Stock | 228 | 90.65 | 20.7K | 16,221 | — | ↗ |
| 2023-09-11 | Lingamneni Anila | Officer | S-Sale | D | Common Stock | 2,305 | 90.00 | 207.5K | 14,495 | — | ↗ |
| 2023-09-05 | Dockendorff Charles J | Director | S-Sale | D | Common Stock | 10,215 | 87.68 | 895.7K | 2,226 | — | ↗ |
| 2023-08-04 | Zane Ellen M | Director | A-Award | A | Common Stock | 2,226 | 0.00 | — | 14,473 | — | ↗ |
| 2023-08-04 | Pomeroy Claire | Director | A-Award | A | Common Stock | 2,226 | 0.00 | — | 11,972 | — | ↗ |
| 2023-08-04 | KROLL MARK W | Director | A-Award | A | Common Stock | 2,226 | 0.00 | — | 18,457 | — | ↗ |
| 2023-08-04 | Johnson Lloyd Emerson | Director | A-Award | A | Common Stock | 2,226 | 0.00 | — | 8,033 | — | ↗ |
| 2023-08-04 | Dockendorff Charles J | Director | A-Award | A | Common Stock | 2,226 | 0.00 | — | 12,441 | — | ↗ |
| 2023-08-04 | COYLE MICHAEL J | Director | A-Award | A | Common Stock | 2,226 | 0.00 | — | 10,494 | — | ↗ |
| 2023-08-04 | Bryant Diane M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-04 | ABERNATHY ROBERT E | Director | A-Award | A | Common Stock | 2,226 | 0.00 | — | 20,081 | — | ↗ |
| 2023-07-18 | Llorens Josep | Officer | S-Sale | D | Common Stock | 4,928 | 90.00 | 443.5K | 18,463 | — | ↗ |
| 2023-06-29 | Simon, Christopher | Director / Officer | M-Exempt | A | Common Stock | 196,746 | 28.62 | 5.63M | 414,113 | — | ↗ |
| 2023-06-07 | Strong Stewart W | Officer | M-Exempt | A | Common Stock | 2,410 | 57.60 | 138.8K | 24,040 | — | ↗ |
| 2023-06-02 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 194 | 86.57 | 16.8K | 14,572 | — | ↗ |
| 2023-05-30 | Lingamneni Anila | Officer | S-Sale | D | Common Stock | 2,304 | 83.33 | 192.0K | 16,800 | — | ↗ |
| 2023-05-18 | Strong Stewart W | Officer | F-InKind | D | Common Stock | 1,087 | 83.34 | 90.6K | 17,147 | — | ↗ |
| 2023-05-18 | Simon, Christopher | Director / Officer | F-InKind | D | Common Stock | 3,839 | 83.34 | 319.9K | 217,367 | — | ↗ |
| 2023-05-18 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 90 | 83.34 | 7.5K | 14,766 | — | ↗ |
| 2023-05-18 | Llorens Josep | Officer | F-InKind | D | Common Stock | 1,423 | 83.34 | 118.6K | 18,463 | — | ↗ |
| 2023-05-18 | Lingamneni Anila | Officer | F-InKind | D | Common Stock | 1,385 | 83.34 | 115.4K | 19,104 | — | ↗ |
| 2023-05-18 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 3,541 | 83.34 | 295.1K | 32,469 | — | ↗ |
| 2023-05-16 | Strong Stewart W | Officer | F-InKind | D | Common Stock | 250 | 89.21 | 22.3K | 18,234 | — | ↗ |
| 2023-05-16 | Simon, Christopher | Director / Officer | F-InKind | D | Common Stock | 1,586 | 89.21 | 141.5K | 221,206 | — | ↗ |
| 2023-05-16 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 235 | 89.21 | 21.0K | 14,856 | — | ↗ |
| 2023-05-16 | Llorens Josep | Officer | F-InKind | D | Common Stock | 319 | 89.21 | 28.5K | 19,886 | — | ↗ |
| 2023-05-16 | Lingamneni Anila | Officer | F-InKind | D | Common Stock | 318 | 89.21 | 28.4K | 20,489 | — | ↗ |
| 2023-05-16 | DArecca James | Officer | F-InKind | D | Common Stock | 349 | 89.21 | 31.1K | 14,102 | — | ↗ |
| 2023-05-16 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 446 | 89.21 | 39.8K | 36,010 | — | ↗ |
| 2023-05-15 | Strong Stewart W | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 6,335 | 89.16 | 564.8K | 6,335 | — | ↗ |
| 2023-05-15 | Simon, Christopher | Director / Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 41,177 | 89.16 | 3.67M | 41,177 | — | ↗ |
| 2023-05-15 | Miller Laurie A. | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 4,751 | 89.16 | 423.6K | 4,751 | — | ↗ |
| 2023-05-15 | Maunsell Farris Maryanne | Officer | A-Award | A | Common Stock | 630 | 0.00 | — | 630 | — | ↗ |
| 2023-05-15 | Llorens Josep | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 6,968 | 89.16 | 621.3K | 6,968 | — | ↗ |
| 2023-05-15 | Lingamneni Anila | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 7,602 | 89.16 | 677.8K | 7,602 | — | ↗ |
| 2023-05-15 | Galvin Roy | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 5,068 | 89.16 | 451.9K | 5,068 | — | ↗ |
| 2023-05-15 | DArecca James | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 9,502 | 89.16 | 847.2K | 9,502 | — | ↗ |
| 2023-05-15 | Basil Michelle L | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 9,502 | 89.16 | 847.2K | 9,502 | — | ↗ |
| 2023-05-12 | Simon, Christopher | Director / Officer | F-InKind | D | Common Stock | 854 | 88.16 | 75.3K | 204,567 | — | ↗ |
| 2023-05-12 | Miller Laurie A. | Officer | F-InKind | D | Common Stock | 32 | 88.16 | 2.8K | 12,989 | — | ↗ |
| 2023-05-12 | Llorens Josep | Officer | F-InKind | D | Common Stock | 113 | 88.16 | 10.0K | 17,121 | — | ↗ |
| 2023-05-12 | Basil Michelle L | Officer | F-InKind | D | Common Stock | 204 | 88.16 | 18.0K | 32,251 | — | ↗ |
| 2023-05-02 | DArecca James | Officer | F-InKind | D | Common Stock | 430 | 81.66 | 35.1K | 10,246 | — | ↗ |
| 2023-04-14 | Lingamneni Anila | Officer | F-InKind | D | Common Stock | 176 | 84.78 | 14.9K | 17,146 | — | ↗ |
| 2023-01-23 | Llorens Josep | Officer | M-Exempt | A | Common Stock | 2,391 | 56.57 | 135.3K | 19,625 | — | ↗ |
| 2022-11-11 | Simon, Christopher | Officer | G-Gift | D | Common Stock | 8,600 | 0.00 | — | 205,124 | — | ↗ |
| 2022-11-01 | Galvin Roy | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 5,263 | 0.00 | — | 5,263 | — | ↗ |
| 2022-10-24 | Strong Stewart W | Officer | S-Sale | D | Common Stock | 75 | 80.39 | 6.0K | 15,681 | — | ↗ |
| 2022-10-24 | Basil Michelle L | Officer | S-Sale | D | Common Stock | 180 | 80.39 | 14.5K | 32,455 | — | ↗ |
| 2022-10-17 | Maunsell Farris Maryanne | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-10-10 | Galvin Roy | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-09-19 | Miller Laurie A. | Officer | S-Sale | D | Common Stock | 212 | 76.25 | 16.2K | 12,697 | — | ↗ |
| 2022-09-19 | Basil Michelle L | Officer | M-Exempt | A | Common Stock | 1,011 | 56.57 | 57.2K | 44,083 | — | ↗ |
| 2022-09-15 | Basil Michelle L | Officer | S-Sale | D | Common Stock | 6,029 | 78.50 | 473.3K | 35,395 | — | ↗ |
| 2022-09-06 | Llorens Josep | Officer | S-Sale | D | Common Stock | 101 | 73.78 | 7.5K | 17,234 | — | ↗ |
| 2022-08-15 | KROLL MARK W | Director | S-Sale | D | Common Stock | 8,016 | 73.71 | 590.9K | 16,231 | — | ↗ |
| 2022-08-05 | Zane Ellen M | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 12,247 | — | ↗ |
| 2022-08-05 | Pomeroy Claire | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 9,746 | — | ↗ |
| 2022-08-05 | KROLL MARK W | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 24,247 | — | ↗ |
| 2022-08-05 | Johnson Lloyd Emerson | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 5,807 | — | ↗ |
| 2022-08-05 | Dockendorff Charles J | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 28,130 | — | ↗ |
| 2022-08-05 | COYLE MICHAEL J | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 8,268 | — | ↗ |
| 2022-08-05 | BURZIK CATHERINE M | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 19,545 | — | ↗ |
| 2022-08-05 | ABERNATHY ROBERT E | Director | A-Award | A | Common Stock | 2,730 | 0.00 | — | 17,855 | — | ↗ |
| 2022-07-05 | Miller Laurie A. | Officer | S-Sale | D | Common Stock | 42 | 66.18 | 2.8K | 12,909 | — | ↗ |
| 2022-06-13 | Simon, Christopher | Officer | S-Sale | D | Common Stock | 1,148 | 62.60 | 71.9K | 213,724 | — | ↗ |
| 2022-06-13 | Miller Laurie A. | Officer | S-Sale | D | Common Stock | 30 | 62.60 | 1.9K | 12,951 | — | ↗ |
| 2022-06-13 | Goldstein Dan | Officer | S-Sale | D | Common Stock | 42 | 62.60 | 2.6K | 4,447 | — | ↗ |
| 2022-06-13 | Basil Michelle L | Officer | S-Sale | D | Common Stock | 277 | 62.60 | 17.3K | 40,635 | — | ↗ |
| 2022-06-02 | Miller Laurie A. | Officer | S-Sale | D | Common Stock | 198 | 62.69 | 12.4K | 12,981 | — | ↗ |
| 2022-06-02 | Goldstein Dan | Officer | S-Sale | D | Common Stock | 249 | 62.69 | 15.6K | 4,489 | — | ↗ |
| 2022-05-19 | Strong Stewart W | Officer | S-Sale | D | Common Stock | 1,084 | 59.10 | 64.1K | 15,756 | — | ↗ |
| 2022-05-19 | Simon, Christopher | Officer | S-Sale | D | Common Stock | 2,496 | 59.10 | 147.5K | 214,872 | — | ↗ |
| 2022-05-19 | Miller Laurie A. | Officer | S-Sale | D | Common Stock | 91 | 59.10 | 5.4K | 13,179 | — | ↗ |
| 2022-05-19 | Llorens Josep | Officer | S-Sale | D | Common Stock | 1,418 | 59.10 | 83.8K | 17,335 | — | ↗ |
| 2022-05-19 | Lingamneni Anila | Officer | S-Sale | D | Common Stock | 1,384 | 59.10 | 81.8K | 17,322 | — | ↗ |
| 2022-05-19 | Goldstein Dan | Officer | S-Sale | D | Common Stock | 134 | 59.10 | 7.9K | 4,738 | — | ↗ |
| 2022-05-19 | Basil Michelle L | Officer | S-Sale | D | Common Stock | 3,258 | 59.10 | 192.5K | 40,912 | — | ↗ |
| 2022-05-16 | Strong Stewart W | Officer | A-Award | A | Common Stock | 4,123 | 0.00 | — | 16,840 | — | ↗ |
| 2022-05-16 | Simon, Christopher | Officer | S-Sale | D | Common Stock | 832 | 56.10 | 46.7K | 191,327 | — | ↗ |
| 2022-05-16 | Miller Laurie A. | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 7,104 | 0.00 | — | 7,104 | — | ↗ |
| 2022-05-16 | Llorens Josep | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 10,148 | 57.60 | 584.5K | 10,148 | — | ↗ |
| 2022-05-16 | Lingamneni Anila | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 10,148 | 0.00 | — | 10,148 | — | ↗ |
| 2022-05-16 | Goldstein Dan | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 2,029 | 57.60 | 116.9K | 2,029 | — | ↗ |
| 2022-05-16 | DArecca James | Officer | A-Award | A | Common Stock | 4,774 | 0.00 | — | 10,676 | — | ↗ |
| 2022-05-16 | Basil Michelle L | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 14,208 | 0.00 | — | 14,208 | — | ↗ |
| 2022-05-02 | DArecca James | Officer | A-Award | A | Common Stock | 5,902 | 0.00 | — | 5,902 | — | ↗ |
| 2022-04-18 | Lingamneni Anila | Officer | S-Sale | D | Common Stock | 189 | 56.55 | 10.7K | 14,013 | — | ↗ |
| 2022-04-11 | DArecca James | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-25 | Strong Stewart W | Officer | S-Sale | D | Common Stock | 75 | 71.93 | 5.4K | 12,717 | — | ↗ |
| 2021-10-25 | Basil Michelle L | Officer | S-Sale | D | Common Stock | 120 | 71.93 | 8.6K | 38,290 | — | ↗ |
| 2021-09-17 | Miller Laurie A. | Officer | A-Award | A | Common Stock | 2,848 | 0.00 | — | 10,081 | — | ↗ |
| 2021-09-07 | Llorens Josep | Officer | S-Sale | D | Common Stock | 100 | 64.61 | 6.5K | 14,520 | — | ↗ |
| 2021-08-30 | Miller Laurie A. | Officer | — | — | Non-qualified Stock Option (Right to Buy) | 1,246 | 98.03 | 122.1K | 0 | D | ↗ |
| 2021-08-23 | Burke William P. Mr. | Officer | S-Sale | D | Common Stock | 22,667 | 60.51 | 1.37M | 30,291 | — | ↗ |
| 2021-08-06 | Zane Ellen M | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 9,517 | — | ↗ |
| 2021-08-06 | Strong Stewart W | Officer | — | D | Common Stock | 0 | 0.00 | — | 12,792 | — | ↗ |
| 2021-08-06 | Pomeroy Claire | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 7,016 | — | ↗ |
| 2021-08-06 | Nikel Chad M. | Officer | — | D | Non-qualified Stock Option (Right to Buy) | 8,966 | 56.57 | 507.2K | 0 | — | ↗ |
| 2021-08-06 | KROLL MARK W | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 21,517 | — | ↗ |
| 2021-08-06 | Johnson Lloyd Emerson | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 3,077 | — | ↗ |
| 2021-08-06 | Dockendorff Charles J | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 25,400 | — | ↗ |
| 2021-08-06 | COYLE MICHAEL J | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 5,538 | — | ↗ |
| 2021-08-06 | BURZIK CATHERINE M | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 16,815 | — | ↗ |
| 2021-08-06 | ABERNATHY ROBERT E | Director | A-Award | A | Common Stock | 3,077 | 0.00 | — | 15,125 | — | ↗ |
| 2021-07-01 | Burke William P. Mr. | Officer | S-Sale | D | Common Stock | 4,293 | 66.60 | 285.9K | 30,291 | — | ↗ |
Executive team
Top executives
EBIT / Employee
66.0K
Shares Outstanding
46.47M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Christopher A. Simon President and Chief Executive Officer | 1.10M | — | 7.03M | 1.40M | 1.13M | 64.2K | 10.72M | 78.59% | ↗ |
| 2 | 2025 | James C. D'Arecca Executive Vice President, Chief Financial Officer | 575.6K | — | 1.56M | 425.0K | 381.9K | 29.6K | 2.98M | 66.83% | ↗ |
| 3 | 2025 | Michelle L. Basil Executive Vice President, General Counsel | 537.9K | — | 1.47M | 400.0K | 356.2K | 28.7K | 2.79M | 66.98% | ↗ |
| 4 | 2025 | Roy Galvin Executive Vice President, Chief Commercial Officer | 490.2K | — | 1.01M | 275.0K | 378.3K | 41.2K | 2.20M | 58.58% | ↗ |
| 5 | 2025 | Stewart W. Strong Former President, Global Hospital | 476.7K | — | 1.01M | 275.0K | 132.1K | 39.2K | 1.93M | 66.51% | ↗ |
| 6 | 2024 | Christopher A. Simon President and Chief Executive Officer | 1.09M | — | 6.32M | 1.62M | 2.45M | 63.3K | 11.55M | 68.82% | ↗ |
| 7 | 2024 | James C. D'Arecca Executive Vice President, Chief Financial Officer | 548.2K | — | 1.46M | 375.0K | 735.9K | 28.4K | 3.15M | 58.28% | ↗ |
| 8 | 2024 | Michelle L. Basil Executive Vice President, General Counsel | 517.2K | — | 1.46M | 375.0K | 694.6K | 26.2K | 3.07M | 59.70% | ↗ |
| 9 | 2024 | Anila Lingamneni Executive Vice President, Chief Technology Officer | 485.1K | — | 1.17M | 300.0K | 564.9K | 25.6K | 2.54M | 57.69% | ↗ |
| 10 | 2024 | Josep L. Llorens Executive Vice President, Global Manufacturing and Supply Chain | 488.7K | — | 1.07M | 275.0K | 568.6K | 27.2K | 2.43M | 55.35% | ↗ |
| 11 | 2023 | Christopher A. Simon President and Chief Executive Officer | 1.01M | — | 5.92M | 1.50M | 2.20M | 48.6K | 10.69M | 69.48% | ↗ |
| 12 | 2023 | James C. D'Arecca Executive Vice President, Chief Financial Officer | 525.0K | 400.0K | 1.39M | 575.0K | 770.2K | 108.3K | 3.76M | 52.09% | ↗ |
| 13 | 2023 | James C. D'Arecca Executive Vice President, Chief Financial Officer (beginning April 11, 2022) | 525.0K | 400.0K | 1.39M | 575.0K | 770.2K | 108.3K | 3.76M | 52.09% | ↗ |
| 14 | 2023 | Michelle L. Basil Executive Vice President, General Counsel | 498.6K | — | 1.38M | 350.0K | 740.4K | 19.0K | 2.99M | 57.93% | ↗ |
| 15 | 2023 | Josep L. Llorens Executive Vice President, Global Manufacturing and Supply Chain | 474.9K | — | 987.4K | 250.0K | 608.4K | 23.9K | 2.34M | 52.78% | ↗ |
| 16 | 2023 | Anila Lingamneni Executive Vice President, Chief Technology Officer | 467.4K | — | 987.4K | 250.0K | 598.8K | 22.7K | 2.33M | 53.19% | ↗ |
| 17 | 2023 | William P. Burke Executive Vice President, Chief Financial Officer (through April 11, 2022) | 167.7K | 272.5K | — | — | 99.7K | 10.7K | 550.6K | 0.00% | ↗ |
| 18 | 2022 | Christopher A. Simon President and Chief Executive Officer | 945.0K | — | 5.32M | 1.50M | 908.5K | 29.5K | 8.70M | 78.36% | ↗ |
| 19 | 2022 | William P. Burke Executive Vice President, Chief Financial Officer | 543.2K | — | 2.33M | 375.0K | 333.4K | 18.2K | 3.60M | 75.14% | ↗ |
| 20 | 2022 | William P. Burke Executive Vice President, Chief Financial Officer (through April 11, 2022) | 543.2K | — | 2.33M | 375.0K | 333.4K | 18.2K | 3.60M | 75.14% | ↗ |
| 21 | 2022 | Michelle L. Basil Executive Vice President, General Counsel | 477.6K | — | 2.24M | 350.0K | 293.2K | 17.8K | 3.38M | 76.67% | ↗ |
| 22 | 2022 | Stewart W. Strong President, Global Hospital | 410.6K | — | 1.37M | 187.5K | 490.0K | 17.4K | 2.48M | 62.99% | ↗ |
| 23 | 2022 | Josep L. Llorens Executive Vice President, Global Manufacturing and Supply Chain | 440.8K | — | 1.11M | 200.0K | 255.6K | 22.3K | 2.03M | 64.56% | ↗ |
| 24 | 2022 | Anila Lingamneni Executive Vice President, Chief Technology Officer | 441.4K | — | 1.11M | 200.0K | 251.6K | 21.4K | 2.02M | 64.69% | ↗ |
| 25 | 2021 | Christopher A. Simon President and Chief Executive Officer | 963.2K | — | 5.10M | 1.50M | 1.04M | 27.6K | 8.63M | 76.47% | ↗ |
| 26 | 2021 | William P. Burke Executive Vice President, Chief Financial Officer (through April 11, 2022) | 539.3K | — | 1.10M | 325.0K | 370.0K | 16.6K | 2.36M | 60.69% | ↗ |
| 27 | 2021 | William P. Burke Executive Vice President, Chief Financial Officer | 539.3K | — | 1.10M | 325.0K | 370.0K | 16.6K | 2.36M | 60.69% | ↗ |
| 28 | 2021 | Michelle L. Basil Executive Vice President, General Counsel | 474.2K | — | 1.02M | 300.0K | 325.4K | 16.1K | 2.13M | 61.79% | ↗ |
| 29 | 2021 | Anila Lingamneni Executive Vice President, Chief Technogy Officer | 435.0K | 100.0K | 649.5K | 350.0K | 277.0K | 33.4K | 1.84M | 54.18% | ↗ |
| 30 | 2021 | Anila Lingamneni Executive Vice President, Chief Technology Officer | 435.0K | 100.0K | 649.5K | 350.0K | 277.0K | 33.4K | 1.84M | 54.18% | ↗ |
| 31 | 2021 | Josep L. Llorens Executive Vice President, Global Manufacturing and Supply Chain | 413.7K | — | 594.4K | 175.0K | 267.6K | 19.4K | 1.47M | 52.33% | ↗ |
| 32 | 2021 | Josep L. Llorens Senior Vice President, Global Manufacturing and Supply Chain | 413.7K | — | 594.4K | 175.0K | 267.6K | 19.4K | 1.47M | 52.33% | ↗ |
| 33 | 2020 | Christopher A. Simon President and Chief Executive Officer | 937.2K | — | 5.49M | 1.37M | 1.56M | 28.7K | 9.40M | 73.09% | ↗ |
| 34 | 2020 | William P. Burke Executive Vice President, Chief Financial Officer | 525.2K | — | 1.20M | 300.0K | 557.0K | 17.5K | 2.60M | 57.67% | ↗ |
| 35 | 2020 | Michelle L. Basil Executive Vice President, General Counsel | 461.8K | — | 1.30M | 275.0K | 489.8K | 17.2K | 2.54M | 61.89% | ↗ |
| 36 | 2020 | Josep L. Llorens Senior Vice President, Global Manufacturing and Supply Chain | 404.0K | — | 599.2K | 150.0K | 402.9K | 19.9K | 1.58M | 47.54% | ↗ |
| 37 | 2020 | Josep L. Llorens Executive Vice President, Global Manufacturing and Supply Chain | 404.0K | — | 599.2K | 150.0K | 402.9K | 19.9K | 1.58M | 47.54% | ↗ |
| 38 | 2020 | Jacqueline D. Scanlan Senior Vice President, Global Human Resources | 406.5K | — | 599.2K | 150.0K | 369.5K | 16.1K | 1.54M | 48.61% | ↗ |
| 39 | 2019 | Christopher Simon President and Chief Executive Officer | 894.0K | — | 4.59M | 1.06M | 1.98M | 27.7K | 8.55M | 66.07% | ↗ |
| 40 | 2019 | Christopher A. Simon President and Chief Executive Officer | 894.0K | — | 4.59M | 1.06M | 1.98M | 27.7K | 8.55M | 66.07% | ↗ |
| 41 | 2019 | William P. Burke Executive Vice President, Chief Financial Officer | 501.3K | — | 841.2K | 243.7K | 708.9K | 17.2K | 2.31M | 46.92% | ↗ |
| 42 | 2019 | Michelle L. Basil Executive Vice President, General Counsel | 440.8K | — | 862.8K | 250.0K | 578.8K | 16.4K | 2.15M | 51.79% | ↗ |
| 43 | 2019 | Jacqueline D. Scanlan Senior Vice President, Global Human Resources | 388.0K | — | 474.5K | 137.5K | 470.3K | 15.4K | 1.49M | 41.20% | ↗ |
| 44 | 2019 | Said Bolorforosh Executive Vice President, Chief Technology Officer | 339.2K | 150.0K | 301.9K | 87.5K | 448.8K | 83.5K | 1.41M | 27.60% | ↗ |
| 45 | 2018 | Christopher Simon President and Chief Executive Officer | 858.5K | — | 4.40M | 1.06M | 1.40M | 133.8K | 7.85M | 69.53% | ↗ |
| 46 | 2018 | Christopher A. Simon President and Chief Executive Officer | 858.5K | — | 4.40M | 1.06M | 1.40M | 133.8K | 7.85M | 69.53% | ↗ |
| 47 | 2018 | Michelle L. Basil Executive Vice President, General Counsel | 425.8K | 150.0K | 822.7K | 250.0K | 411.3K | 22.4K | 2.08M | 51.52% | ↗ |
| 48 | 2018 | William P. Burke Executive Vice President, Chief Financial Officer | 482.3K | — | 765.1K | 232.5K | 506.7K | 18.0K | 2.00M | 49.76% | ↗ |
| 49 | 2018 | Jacqueline D. Scanlan Senior Vice President, Global Human Resources | 375.0K | 100.0K | 386.6K | 117.5K | 301.7K | 138.3K | 1.42M | 35.52% | ↗ |
| 50 | 2018 | Neil Ryding Executive Vice President, Global Operations | 432.2K | — | 329.1K | 100.0K | 208.6K | 20.7K | 1.09M | 39.34% | ↗ |
| 51 | 2017 | Christopher Simon President and Chief Executive Officer | 709.6K | — | 6.21M | 1.31M | 698.7K | 100.3K | 9.03M | 83.29% | ↗ |
| 52 | 2017 | William P. Burke EVP, Chief Financial Officer | 301.5K | 500.0K | 1.07M | 356.2K | 210.5K | 13.2K | 2.45M | 58.18% | ↗ |
| 53 | 2017 | William P. Burke Executive Vice President, Chief Financial Officer | 301.5K | 500.0K | 1.07M | 356.2K | 210.5K | 13.2K | 2.45M | 58.18% | ↗ |
| 54 | 2017 | Neil Ryding Executive Vice President, Global Operations | 428.2K | — | 337.9K | 112.5K | 198.9K | 317.4K | 1.42M | 31.78% | ↗ |
| 55 | 2017 | Neil Ryding EVP, Global Operations | 428.2K | — | 337.9K | 112.5K | 198.9K | 317.4K | 1.42M | 31.78% | ↗ |
| 56 | 2017 | Byron Selman President, Global Markets | 454.0K | — | 394.3K | 131.2K | 234.3K | 72.0K | 1.28M | 41.03% | ↗ |
| 57 | 2017 | Sandra Jesse EVP, Chief Legal Officer | 419.5K | — | 337.9K | 112.5K | 217.4K | 30.2K | 1.11M | 40.48% | ↗ |
| 58 | 2017 | Ronald G. Gelbman Interim CEO | 155.2K | 715.0K | — | — | — | 43.2K | 875.7K | 0.00% | ↗ |
| 59 | 2017 | Christopher Lindop CFO and EVP, Business Development | 128.4K | — | — | — | — | 53.5K | 181.9K | 0.00% | ↗ |
| 60 | 2016 | Kent Davies Chief Operating Officer | 567.8K | — | 883.3K | 312.5K | 40.0K | 8.3K | 1.81M | 66.00% | ↗ |
| 61 | 2016 | Christopher Lindop CFO and EVP, Business Development | 500.6K | — | 915.3K | 200.0K | 35.0K | 5.6K | 1.64M | 68.20% | ↗ |
| 62 | 2016 | David Fusco EVP, Global Human Resources | 242.3K | — | 735.2K | 332.5K | 100.0K | 80.5K | 1.49M | 71.63% | ↗ |
| 63 | 2016 | Byron Selman President, Global Markets | 452.5K | — | 723.8K | 125.0K | 45.0K | 30.5K | 1.38M | 61.65% | ↗ |
| 64 | 2016 | Brian Concannon President and CEO | 456.2K | — | — | — | — | 269.3K | 725.5K | 0.00% | ↗ |
| 65 | 2016 | Ronald G. Gelbman Interim CEO | 398.8K | — | — | — | — | 201.7K | 600.4K | 0.00% | ↗ |
| 66 | 2016 | Ronald Gelbman Interim CEO through May, 2016, Director | 398.8K | — | — | — | — | 201.7K | 600.4K | 0.00% | ↗ |
| 67 | 2015 | Brian Concannon President and CEO | 640.2K | — | 2.83M | 937.5K | 442.8K | 6.9K | 4.86M | 77.57% | ↗ |
| 68 | 2015 | Kent Davies Chief Operating Officer | 401.9K | — | 625.0K | 398.7K | 218.5K | 30.5K | 1.67M | 61.13% | ↗ |
| 69 | 2015 | Christopher Lindop CFO and EVP, Business Development | 478.3K | — | 566.1K | 187.5K | 211.8K | 43.9K | 1.49M | 50.66% | ↗ |
| 70 | 2015 | Peter Allen President, Global Plasma | 451.7K | — | 524.9K | 175.0K | 175.4K | 6.9K | 1.33M | 52.47% | ↗ |
| 71 | 2015 | Brian Burns EVP, Global QA/RA | 417.3K | 300.0K | 318.7K | 106.2K | 148.9K | 6.9K | 1.30M | 32.74% | ↗ |
| 72 | 2015 | Byron Selman President, Global Markets | 398.8K | — | 245.3K | 81.2K | 144.1K | 33.7K | 903.1K | 36.16% | ↗ |
| 73 | 2014 | Brian Concannon President and CEO | 594.2K | — | 2.92M | 2.45M | — | 6.6K | 5.97M | 89.94% | ↗ |
| 74 | 2014 | Christopher Lindop CFO and EVP, Business Development | 462.8K | 250.0K | 1.15M | 490.0K | 70.2K | 6.6K | 2.29M | 71.43% | ↗ |
| 75 | 2014 | Kathleen McDaniel EVP, Global Human Resources | 340.0K | — | 1.17M | 542.5K | 76.5K | 6.6K | 2.13M | 80.17% | ↗ |
| 76 | 2014 | Peter Allen President, Global Plasma | 434.0K | 150.0K | 1.07M | 315.0K | 96.9K | 6.6K | 2.07M | 66.83% | ↗ |
| 77 | 2014 | Jonathan White Chief Science Technology Officer | 441.0K | — | 1.06M | 297.5K | 49.6K | 6.6K | 1.77M | 76.95% | ↗ |
| 78 | 2014 | Brian Burns EVP, Global QA/RA | 71.8K | — | 1.02M | 245.0K | 46.7K | — | 1.39M | 91.45% | ↗ |
| 79 | 2014 | Byron Selman President, Global Markets | 388.3K | — | 542.7K | 175.0K | 39.0K | 9.7K | 1.15M | 62.16% | ↗ |
| 80 | 2013 | Brian Concannon President and CEO | 571.3K | — | 1.05M | 2.47M | 444.1K | 6.6K | 4.55M | 77.53% | ↗ |
| 81 | 2013 | Brian Concannon President Chief Executive Officer | 571.3K | — | 1.05M | 2.47M | 444.1K | 6.6K | 4.55M | 77.53% | ↗ |
| 82 | 2013 | David Helsel EVP, Global Manufacturing | 355.0K | 100.0K | 239.9K | 559.7K | 124.5K | 6.6K | 1.39M | 57.70% | ↗ |
| 83 | 2013 | Christopher Lindop, CFO EVP, Business Development | 446.8K | — | 195.7K | 459.3K | 191.8K | 40.2K | 1.33M | 49.11% | ↗ |
| 84 | 2013 | Christopher Lindop CFO and EVP, Business Development | 446.8K | — | 195.7K | 459.3K | 191.8K | 40.2K | 1.33M | 49.11% | ↗ |
| 85 | 2013 | Michael Kelly President, Global Markets | 430.4K | — | 165.6K | 388.6K | 158.6K | 41.6K | 1.18M | 46.78% | ↗ |
| 86 | 2013 | Peter Allen President, Global Plasma | 418.9K | 100.0K | 135.5K | 318.0K | 147.7K | 6.6K | 1.13M | 40.25% | ↗ |
| 87 | 2013 | Jonathan White Chief Science Technology Officer | 424.0K | — | 135.5K | 318.0K | 145.8K | 6.6K | 1.03M | 44.03% | ↗ |
| 88 | 2012 | Brian Concannon President and CEO | 550.0K | — | 749.9K | 1.76M | 149.2K | 6.6K | 3.21M | 78.03% | ↗ |
| 89 | 2012 | Brian Concannon President Chief Executive Officer | 550.0K | — | 749.9K | 1.76M | 149.2K | 6.6K | 3.21M | 78.03% | ↗ |
| 90 | 2012 | Jonathan White Vice President, Research Development | 404.0K | 25.0K | 369.9K | 534.8K | 66.6K | 6.6K | 1.41M | 64.31% | ↗ |
| 91 | 2012 | Jonathan White Chief Science Technology Officer | 404.0K | 25.0K | 369.9K | 534.8K | 66.6K | 6.6K | 1.41M | 64.31% | ↗ |
| 92 | 2012 | Michael Kelly President, Global Markets | 388.4K | — | 127.5K | 298.6K | 94.0K | 278.4K | 1.19M | 35.90% | ↗ |
| 93 | 2012 | Michael Kelly President, North America | 388.4K | — | 127.5K | 298.6K | 94.0K | 278.4K | 1.19M | 35.90% | ↗ |
| 94 | 2012 | Christopher Lindop CFO and EVP, Business Development | 430.3K | — | 164.9K | 386.4K | 87.3K | 6.6K | 1.08M | 51.26% | ↗ |
| 95 | 2012 | Christopher Lindop, CFO EVP, Business Development | 430.3K | — | 164.9K | 386.4K | 87.3K | 6.6K | 1.08M | 51.26% | ↗ |
| 96 | 2012 | Christopher Lindop, Chief Financial Officer Vice President, Business Development | 430.3K | — | 164.9K | 386.4K | 87.3K | 6.6K | 1.08M | 51.26% | ↗ |
| 97 | 2012 | Mikael Gordon Vice President, Global Markets | 490.4K | — | 120.0K | 281.0K | 84.7K | 67.1K | 1.04M | 38.44% | ↗ |
| 98 | 2012 | Peter Allen President, Global Plasma | 408.8K | — | 105.0K | 245.9K | 89.0K | 6.6K | 855.3K | 41.02% | ↗ |
| 99 | 2011 | Brian Concannon President Chief Executive Officer | 550.0K | — | 752.3K | 1.76M | — | 6.6K | 3.07M | 81.88% | ↗ |
| 100 | 2011 | Brian Concannon President and Chief Executive Officer | 550.0K | — | 752.3K | — | — | 6.6K | 3.07M | 24.49% | ↗ |
| 101 | 2011 | Michael Ruxin, M.D. | 246.2K | — | — | — | — | 935.5K | 3.02M | 0.00% | ↗ |
| 102 | 2011 | Michael Kelly President, North America | 259.6K | 100.0K | 118.5K | 465.4K | — | 43.4K | 986.9K | 59.16% | ↗ |
| 103 | 2011 | Michael Kelly President, Global Markets | 259.6K | 100.0K | 118.5K | 465.4K | — | 43.4K | 986.9K | 59.16% | ↗ |
| 104 | 2011 | Christopher Lindop, Chief Financial Officer Vice President, Business Development | 426.1K | — | 159.5K | 373.8K | — | 6.6K | 966.0K | 55.20% | ↗ |
| 105 | 2011 | Christopher Lindop Chief financial Officer and Vice President Business Development | 426.1K | — | 159.5K | — | — | 6.6K | 966.0K | 16.51% | ↗ |
| 106 | 2011 | Christopher Lindop, CFO EVP, Business Development | 426.1K | — | 159.5K | 373.8K | — | 6.6K | 966.0K | 55.20% | ↗ |
| 107 | 2011 | Peter Allen President, Global Plasma | 403.1K | 200.0K | 97.8K | 229.2K | — | 4.0K | 934.1K | 35.01% | ↗ |
| 108 | 2011 | Peter Allen Chief Marketing Officer | 403.1K | 200.0K | 97.8K | — | — | 4.0K | 934.1K | 10.47% | ↗ |
| 109 | 2011 | Mikael Gordon President, Global Markets | 417.8K | — | 120.4K | — | 16.3K | 46.6K | 883.1K | 13.63% | ↗ |
| 110 | 2011 | Mikael Gordon Vice President, Global Markets | 417.8K | — | 120.4K | 282.1K | 16.3K | 46.6K | 883.1K | 45.57% | ↗ |
| 111 | 2010 | Brian Concannon President Chief Executive Officer | 546.2K | 200.0K | 369.8K | 1.71M | 350.7K | 6.3K | 3.19M | 65.36% | ↗ |
| 112 | 2010 | Brian Concannon President and Chief Executive Officer | 546.2K | 200.0K | 369.8K | — | 350.7K | 6.3K | 3.19M | 11.61% | ↗ |
| 113 | 2010 | Brian Concannon President CEO | 546.2K | 200.0K | — | — | — | — | 3.19M | 0.00% | ↗ |
| 114 | 2010 | Christopher Lindop Chief financial Officer and Vice President Business Development | 420.3K | — | 71.8K | — | 160.3K | 6.3K | 987.3K | 7.27% | ↗ |
| 115 | 2010 | Christopher Lindop Chief Financial Officer Vice President of Business Development | 420.3K | — | — | — | — | — | 987.3K | 0.00% | ↗ |
| 116 | 2010 | Christopher Lindop, Chief Financial Officer Vice President, Business Development | 420.3K | — | 71.8K | 328.7K | 160.3K | 6.3K | 987.3K | 40.56% | ↗ |
| 117 | 2010 | Mikael Gordon Vice President, Global Markets | 385.4K | — | 63.8K | 292.2K | 117.5K | 61.3K | 920.3K | 38.68% | ↗ |
| 118 | 2010 | Mikael Gordon President, Global Markets | 385.4K | — | 63.8K | — | 117.5K | 61.3K | 920.3K | 6.93% | ↗ |
| 119 | 2010 | Mikael Gordon President, Global Markets | 385.4K | — | — | — | — | — | 920.3K | 0.00% | ↗ |
| 120 | 2010 | Alicia Lopez | 393.2K | 200.0K | — | — | — | — | 892.2K | 0.00% | ↗ |
| 121 | 2010 | Peter Allen Chief Marketing Officer | 398.6K | — | 51.0K | — | 152.9K | 4.0K | 840.2K | 6.07% | ↗ |
| 122 | 2010 | Brad Nutter Executive Chairman of the Board | 323.5K | — | — | — | — | — | 448.3K | 0.00% | ↗ |
| 123 | 2009 | Brad Nutter Chief Executive Officer | 520.0K | — | 21.4K | — | 761.3K | — | 3.07M | 0.70% | ↗ |
| 124 | 2009 | Brad Nutter Executive Chairman of the Board | 520.0K | — | — | — | — | — | 2.55M | 0.00% | ↗ |
| 125 | 2009 | Christopher Lindop Chief financial Officer and Vice President Business Development | 400.5K | — | 236.9K | — | 255.8K | — | 2.09M | 11.34% | ↗ |
| 126 | 2009 | Christopher Lindop Chief Financial Officer Vice President of Business Development | 400.5K | — | — | — | — | — | 2.09M | 0.00% | ↗ |
| 127 | 2009 | Brian Concannon President CEO | 423.2K | — | — | — | — | — | 1.31M | 0.00% | ↗ |
| 128 | 2009 | Brian Concannon President and Chief Executive Officer | 423.2K | — | 96.4K | — | 310.0K | 8.9K | 1.31M | 7.38% | ↗ |
| 129 | 2009 | Brian P. Concannon Chief Operating Officer | 423.2K | — | 139.1K | — | 310.0K | 8.9K | 1.17M | 11.86% | ↗ |
| 130 | 2009 | Christopher Lindop Vice President, Finance and Chief Financial Officer | 400.5K | — | 36.5K | — | 255.8K | — | 1.13M | 3.23% | ↗ |
| 131 | 2009 | Peter Allen Chief Marketing Officer | 384.5K | — | 51.4K | — | 274.6K | 8.9K | 968.8K | 5.30% | ↗ |
| 132 | 2009 | Robert B. Ebbeling Vice President, Technical Operations | 396.7K | — | 14.6K | — | 252.9K | 6.0K | 962.4K | 1.52% | ↗ |
| 133 | 2009 | Peter M. Allen President, Donor Division Chief Marketing Officer | 384.5K | — | 19.2K | — | 274.6K | 8.9K | 938.3K | 2.04% | ↗ |
| 134 | 2008 | Brad Nutter Chief Executive Officer | 520.0K | — | — | — | 308.0K | 110.00 | 2.68M | 0.00% | ↗ |
| 135 | 2008 | Peter M. Allen President, Donor Division Chief Marketing Officer | 376.9K | 200.0K | 5.8K | — | 123.7K | 8.0K | 1.03M | 0.56% | ↗ |
| 136 | 2008 | Brian P. Concannon Chief Operating Officer | 400.1K | — | 108.1K | — | 114.2K | 18.4K | 975.6K | 11.08% | ↗ |
| 137 | 2008 | Christopher Lindop Chief Financial Officer Vice President of Business Development | 385.0K | — | — | — | — | — | 915.2K | 0.00% | ↗ |
| 138 | 2008 | Brad Nutter Executive Chairman of the Board | 520.0K | — | — | — | — | — | 828.2K | 0.00% | ↗ |
| 139 | 2008 | Christopher Lindop Vice President, Finance and Chief Financial Officer | 385.0K | — | 6.7K | — | 99.5K | 102.00 | 777.8K | 0.87% | ↗ |
| 140 | 2008 | Robert B. Ebbeling Vice President, Technical Operations | 384.3K | — | 6.0K | — | 98.2K | 6.3K | 705.8K | 0.85% | ↗ |
| 141 | 2007 | Brad Nutter President CEO | 518.1K | — | — | 3.90M | — | 2.3K | 4.42M | 88.23% | ↗ |
| 142 | 2007 | Brad Nutter Chief Executive Officer | 518.1K | — | — | — | — | 2.3K | 2.88M | 0.00% | ↗ |
| 143 | 2007 | Christopher Lindop Vice President, Finance and Chief Financial Officer | 87.4K | 300.0K | — | 1.02M | — | 287.00 | 1.41M | 72.43% | ↗ |
| 144 | 2007 | Brian P. Concannon Chief Operating Officer | 382.9K | 200.0K | — | — | — | 19.3K | 981.0K | 0.00% | ↗ |
| 145 | 2007 | Brian P Concannon | 382.9K | 200.0K | — | 324.7K | — | 19.3K | 926.8K | 35.04% | ↗ |
| 146 | 2007 | Robert B Ebbeling | 376.3K | 200.0K | — | 324.7K | — | 8.5K | 909.6K | 35.70% | ↗ |
| 147 | 2007 | Peter M. Allen President, Donor Division Chief Marketing Officer | 376.0K | — | — | — | — | 16.0K | 764.6K | 0.00% | ↗ |
| 148 | 2007 | Robert B. Ebbeling Vice President, Technical Operations | 376.3K | 200.0K | — | — | — | 8.5K | 759.5K | 0.00% | ↗ |
| 149 | 2007 | Peter M Allen | 376.0K | — | — | 324.7K | — | 16.0K | 716.7K | 45.31% | ↗ |
| 150 | 2007 | Ronald J Ryan | 288.5K | 128.8K | — | — | — | 75.1K | 492.4K | 0.00% | ↗ |
| 151 | 2007 | Christopher Lindop Vice President, Finance and Chief Financial Officer | 87.4K | 300.0K | — | — | — | 287.00 | 429.3K | 0.00% | ↗ |
| 152 | 2006 | Brad Nutter President CEO | 500.0K | 524.3K | — | — | — | — | 1.02M | 0.00% | ↗ |
| 153 | 2006 | Brian Concannon President, Patient Division | 368.3K | 174.4K | — | — | — | 6.0K | 548.7K | 0.00% | ↗ |
| 154 | 2006 | Peter Allen President, Donor Division | 366.7K | 172.6K | — | — | — | 3.7K | 542.9K | 0.00% | ↗ |
| 155 | 2006 | Ronald Ryan VP, Finance, CFO | 326.9K | 157.4K | — | — | — | 6.0K | 490.3K | 0.00% | ↗ |
| 156 | 2006 | Robert Ebbeling VP, Operations | 300.5K | 127.2K | — | — | — | 6.0K | 433.7K | 0.00% | ↗ |
| 157 | 2005 | Brad Nutter President CEO | 500.0K | 370.8K | — | — | — | — | 870.8K | 0.00% | ↗ |
| 158 | 2005 | Brian Concannon President, Patient Division | 356.3K | 170.3K | — | — | — | 6.0K | 532.6K | 0.00% | ↗ |
| 159 | 2005 | Peter Allen President, Donor Division | 356.3K | 170.3K | — | — | — | 1.6K | 528.2K | 0.00% | ↗ |
| 160 | 2005 | Ronald Ryan VP, Finance, CFO | 318.3K | 155.6K | — | — | — | 6.0K | 480.0K | 0.00% | ↗ |
| 161 | 2005 | Robert Ebbeling VP, Operations | 289.1K | 124.2K | — | — | — | 6.0K | 419.3K | 0.00% | ↗ |
| 162 | 2004 | Brad Nutter President CEO | 500.0K | 225.0K | — | — | — | — | 725.0K | 0.00% | ↗ |
| 163 | 2004 | Ronald Ryan VP, Finance, CFO | 306.0K | 129.6K | — | — | — | 6.0K | 441.6K | 0.00% | ↗ |
| 164 | 2004 | Robert Ebbeling VP, Operations | 277.3K | 103.4K | — | — | — | 6.0K | 386.7K | 0.00% | ↗ |
| 165 | 2004 | Peter Allen President, Donor Division | 208.7K | 82.7K | — | — | — | — | 291.4K | 0.00% | ↗ |
| 166 | 2004 | Brian Concannon President, Patient Division | 188.5K | 82.7K | — | — | — | — | 271.2K | 0.00% | ↗ |
| 167 | 2003 | Ronald Ryan VP, Finance, CFO | 296.4K | — | — | — | — | 6.0K | 302.4K | 0.00% | ↗ |
| 168 | 2003 | Robert Ebbeling VP, Operations | 257.6K | — | — | — | — | 6.0K | 263.6K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Christopher A. Simon | Chief Executive Officer, President & Director | 2M | male |
| James C. D'Arecca | Chief Financial Officer, Executive Vice President & Financial Officer | 987.0K | male |
| Michelle L. Basil | Executive Vice President, General Counsel & Secretary | 922.8K | female |
| Roy Galvin | Executive Vice President & Chief Commercial Officer | 909.6K | male |
| Frank W. Chan | Executive Vice President & Chief Operating Officer | — | male |
| Jan Hartmann | Senior Vice President & Chief Medical Officer | — | — |
| Laurie A. Miller | Senior Vice President & Chief Human Resources Officer | — | female |
| Farris Maryanne Maunsell | Vice President, Chief Accounting Officer & Principal Accounting Officer | — | female |
| Olga Guyette | Senior Director of Investor Relations | — | female |
| Rajeev Varma | Senior Vice President of Strategy & Corporate Development | — | male |
| David J. Wilson | President of Plasma Business Unit | — | male |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2021-05-07 | 2021-05-25 | Lois Frankel | FL21 | Self | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2021-05-06 | 2021-05-25 | Lois Frankel | FL21 | Self | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2021-01-25 | 2021-02-09 | Josh Gottheimer | NJ05 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-10-16 | 2020-11-05 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-09-15 | 2020-10-13 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-08-14 | 2020-08-24 | Lois Frankel | FL21 | Self | Purchase | $1,001 - $15,000 | ↗ |
| 2020-06-01 | 2020-06-16 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-05-28 | 2020-06-10 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-05-19 | 2020-06-16 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-05-15 | 2020-06-10 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HAE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
